{"SPADE_N_05587": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}, {"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_05587", "Peptide Name": "Epilancin 15X(Bacteriocin)", "Source": "Staphylococcus epidermidis 15X154", "Family": "Belongs to the lantibiotics family (Class I bacteriocin)", "Gene": "Not found", "Sequence": "SASIVKTTIKASKKLCRGFTLTCGCHFTGKK", "Sequence Length": 31, "UniProt Entry": ["http://www.uniprot.org/uniprot/P86047"], "Protein Existence": "", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+"], "Target Organism": "Gram-positive", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "The peptide was found to highly resemble the previously identified epilancin K7 with 68% sequence identity, three nearly identical lanthionine rings and a modified amino acid at the N-terminus. The C-terminal B and C rings of epilancin 15X are structurally similar to the D and E rings of nisin A that are believed to be involved in pore formation.", "Formula": "C145H248N42O40S3", "Mass": 3315.97, "PI": 10.07, "Net Charge": 8, "Hydrophobicity": -0.02, "Half Life": "Mammalian:1.9 hourYeast:>20 hourE.coli:>10 hour", "Comments": "The compound contains an unusual N-terminal D-lactate group that could be essential for biological activity. This study demonstrates that this moiety confers stability against proteolytic degradation by aminopeptidases.", "Literature": [{"Title": "Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.", "Pubmed ID": "15792796", "Reference": "FEBS Lett. 2005 Mar 28;579(9)1917-22.", "Author": "Ekkelenkamp MB, Hanssen M, Danny Hsu ST, de Jong A, Milatovic D, Verhoef J, van Nuland NA.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15792796"}, {"Title": "Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate.", "Pubmed ID": "21802007", "Reference": "Chem Biol. 2011 Jul 29;18(7)857-67.", "Author": "Vel", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21802007"}], "Frequent Amino Acids": "KTC", "Absent Amino Acids": "DEMNOPQUWY", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 22, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00027", "Similarity": 1.0, "Sequence": "ASIVKTTIKASKKLCRGFTLTCGCHFTGKK"}, {"SPADE_ID": "SPADE_N_05609", "Similarity": 0.8333333333333334, "Sequence": "ASVVKTTIKASKKLCKGATLTCGCNITGKK"}, {"SPADE_ID": "SPADE_N_08117", "Similarity": 0.7666666666666667, "Sequence": "AAIVKAAIKAAKKLCRGFALACGCHFAGKK"}]}}}